218 related articles for article (PubMed ID: 15327777)
1. The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair.
Lu X; Bocangel D; Nannenga B; Yamaguchi H; Appella E; Donehower LA
Mol Cell; 2004 Aug; 15(4):621-34. PubMed ID: 15327777
[TBL] [Abstract][Full Text] [Related]
2. Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice.
Nannenga B; Lu X; Dumble M; Van Maanen M; Nguyen TA; Sutton R; Kumar TR; Donehower LA
Mol Carcinog; 2006 Aug; 45(8):594-604. PubMed ID: 16652371
[TBL] [Abstract][Full Text] [Related]
3. Homeostatic regulation of base excision repair by a p53-induced phosphatase: linking stress response pathways with DNA repair proteins.
Lu X; Nguyen TA; Appella E; Donehower LA
Cell Cycle; 2004 Nov; 3(11):1363-6. PubMed ID: 15539943
[TBL] [Abstract][Full Text] [Related]
4. Different organization of base excision repair of uracil in DNA in nuclei and mitochondria and selective upregulation of mitochondrial uracil-DNA glycosylase after oxidative stress.
Akbari M; Otterlei M; Peña-Diaz J; Krokan HE
Neuroscience; 2007 Apr; 145(4):1201-12. PubMed ID: 17101234
[TBL] [Abstract][Full Text] [Related]
5. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D.
Lu X; Nguyen TA; Donehower LA
Cell Cycle; 2005 Aug; 4(8):1060-4. PubMed ID: 15970689
[TBL] [Abstract][Full Text] [Related]
6. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints.
Lu X; Nannenga B; Donehower LA
Genes Dev; 2005 May; 19(10):1162-74. PubMed ID: 15870257
[TBL] [Abstract][Full Text] [Related]
7. Strikingly different properties of uracil-DNA glycosylases UNG2 and SMUG1 may explain divergent roles in processing of genomic uracil.
Doseth B; Ekre C; Slupphaug G; Krokan HE; Kavli B
DNA Repair (Amst); 2012 Jun; 11(6):587-93. PubMed ID: 22483865
[TBL] [Abstract][Full Text] [Related]
8. Glycogen Synthase Kinase 3 (GSK-3)-mediated Phosphorylation of Uracil N-Glycosylase 2 (UNG2) Facilitates the Repair of Floxuridine-induced DNA Lesions and Promotes Cell Survival.
Baehr CA; Huntoon CJ; Hoang SM; Jerde CR; Karnitz LM
J Biol Chem; 2016 Dec; 291(52):26875-26885. PubMed ID: 27875297
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.
Nguyen TA; Slattery SD; Moon SH; Darlington YF; Lu X; Donehower LA
DNA Repair (Amst); 2010 Jul; 9(7):813-23. PubMed ID: 20451471
[TBL] [Abstract][Full Text] [Related]
10. Repair of U/G and U/A in DNA by UNG2-associated repair complexes takes place predominantly by short-patch repair both in proliferating and growth-arrested cells.
Akbari M; Otterlei M; Peña-Diaz J; Aas PA; Kavli B; Liabakk NB; Hagen L; Imai K; Durandy A; Slupphaug G; Krokan HE
Nucleic Acids Res; 2004; 32(18):5486-98. PubMed ID: 15479784
[TBL] [Abstract][Full Text] [Related]
11. Post-replicative base excision repair in replication foci.
Otterlei M; Warbrick E; Nagelhus TA; Haug T; Slupphaug G; Akbari M; Aas PA; Steinsbekk K; Bakke O; Krokan HE
EMBO J; 1999 Jul; 18(13):3834-44. PubMed ID: 10393198
[TBL] [Abstract][Full Text] [Related]
12. Uracil-DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms.
Pettersen HS; Sundheim O; Gilljam KM; Slupphaug G; Krokan HE; Kavli B
Nucleic Acids Res; 2007; 35(12):3879-92. PubMed ID: 17537817
[TBL] [Abstract][Full Text] [Related]
13. Direct interaction between XRCC1 and UNG2 facilitates rapid repair of uracil in DNA by XRCC1 complexes.
Akbari M; Solvang-Garten K; Hanssen-Bauer A; Lieske NV; Pettersen HS; Pettersen GK; Wilson DM; Krokan HE; Otterlei M
DNA Repair (Amst); 2010 Jul; 9(7):785-95. PubMed ID: 20466601
[TBL] [Abstract][Full Text] [Related]
14. The rate of base excision repair of uracil is controlled by the initiating glycosylase.
Visnes T; Akbari M; Hagen L; Slupphaug G; Krokan HE
DNA Repair (Amst); 2008 Nov; 7(11):1869-81. PubMed ID: 18721906
[TBL] [Abstract][Full Text] [Related]
15. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.
Zhang M; Xu E; Zhang J; Chen X
Oncogene; 2015 Nov; 34(48):5900-11. PubMed ID: 25823026
[TBL] [Abstract][Full Text] [Related]
16. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity.
Bulavin DV; Demidov ON; Saito S; Kauraniemi P; Phillips C; Amundson SA; Ambrosino C; Sauter G; Nebreda AR; Anderson CW; Kallioniemi A; Fornace AJ; Appella E
Nat Genet; 2002 Jun; 31(2):210-5. PubMed ID: 12021785
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.
Fujimoto H; Onishi N; Kato N; Takekawa M; Xu XZ; Kosugi A; Kondo T; Imamura M; Oishi I; Yoda A; Minami Y
Cell Death Differ; 2006 Jul; 13(7):1170-80. PubMed ID: 16311512
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the active site and a unique uncompetitive inhibitor of the PPM1-type protein phosphatase PPM1D.
Chuman Y; Yagi H; Fukuda T; Nomura T; Matsukizono M; Shimohigashi Y; Sakaguchi K
Protein Pept Lett; 2008; 15(9):938-48. PubMed ID: 18991770
[TBL] [Abstract][Full Text] [Related]
19. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.
Rossi M; Demidov ON; Anderson CW; Appella E; Mazur SJ
Nucleic Acids Res; 2008 Dec; 36(22):7168-80. PubMed ID: 19015127
[TBL] [Abstract][Full Text] [Related]
20. Error-free versus mutagenic processing of genomic uracil--relevance to cancer.
Krokan HE; Sætrom P; Aas PA; Pettersen HS; Kavli B; Slupphaug G
DNA Repair (Amst); 2014 Jul; 19():38-47. PubMed ID: 24746924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
